Department of Nephrology, and.
J Am Soc Nephrol. 2014 Apr;25(4):671-4. doi: 10.1681/ASN.2013090960. Epub 2014 Jan 23.
Adenine phosphoribosyltransferase deficiency is a rare autosomal recessive disorder manifesting as urolithiasis or crystalline nephropathy. It leads to the generation of large amounts of poorly soluble 2,8-dihydroxyadenine excreted in urine, yielding kidney injury and in some patients, kidney failure. Early recognition of the disease, institution of xanthine analog therapy to block the formation of 2,8-dihydroxyadenine, high fluid intake, and low purine diet prevent CKD. Because of symptom variability and lack of awareness, however, the diagnosis is sometimes extremely deferred. We describe a patient with adenine phosphoribosyltransferase deficiency who was diagnosed during evaluation of a poorly functioning second kidney allograft. This report highlights the risk of renal allograft loss in patients with undiagnosed adenine phosphoribosyltransferase deficiency and the need for improved early detection of this disease.
腺嘌呤磷酸核糖基转移酶缺乏症是一种罕见的常染色体隐性遗传病,表现为尿石症或结晶性肾病。它导致大量不易溶解的 2,8-二羟腺嘌呤生成,并在尿液中排泄,导致肾脏损伤,在一些患者中还会导致肾衰竭。早期识别疾病,采用黄嘌呤类似物治疗以阻止 2,8-二羟腺嘌呤的形成,增加液体摄入,以及低嘌呤饮食可预防 CKD。然而,由于症状的可变性和缺乏认识,诊断有时会被极大地延迟。我们描述了一例腺嘌呤磷酸核糖基转移酶缺乏症患者,他是在评估功能不佳的第二个肾脏同种异体移植物时被诊断出来的。本报告强调了未确诊的腺嘌呤磷酸核糖基转移酶缺乏症患者存在肾移植丧失的风险,以及需要改善对此病的早期检测。